You are on page 1of 15
Extraordinary Strategic Advisory Group of Experts on Immunization (SAGE) meeting on Influenza A(H1N1) vaccines 7

Extraordinary Strategic Advisory Group of Experts on Immunization (SAGE) meeting on Influenza A(H1N1) vaccines 7 July 2009 CCV/CICG, Geneva

Provisional list of participants

SAGE members

Professor Jon S. Abramson (Member of H1N1 Working Group) Wake Forest University 1834 Wake Forest Road Winston-Salem

tel: 1 336 716 2512 fax: 1 336 716 9699 e-mail: jabrams@wfubmc.edu

27106

NC

United States of America

Professor Hyam N. Bashour (Unable to attend) Professor of Epidemiology and Community Health, Deputy Dean for Scientific Affairs Department of Family and Community Medicine University of Damascus Faculty of Medicine P.O. Box 9241 Damascus Syria

tel: +963 11 2117403; +963 11 661832 fax: +963 11 2117404 e-mail: hbashour@scs-net.org; hyam- b@scs-net.org

Professor Zulfiqar Ahmed Bhutta (Unable to attend) Head Maternal and Child Health Division The Aga Khan University P.O. Box 3500 Stadium Road Karachi 74800 Pakistan

tel: +92 21 493 9202 fax: +92 21 493 4294 e-mail: Zulfiqar.bhutta@aku.edu

Dr Supamit Chunsuttiwat (Member of H1N1 Working Group) Senior Medical Officer Department of Disease Control Ministry of Public Health Tiwanon Road

tel: +662 590 3370 fax: +662 591 8432 e-mail: schunsu@hotmail.com

11000

Nonthaburi

Thailand

Professor David Durrheim (Linked by telephone) Director of Health Protection, Hunter New England Area Health Service and Professor of Public Health Newcastle University Locked Bag 10 Wallsend 2287 NSW Australia

tel: +61-2-492 46395 fax: +61 2 492 46048 e-mail:

David.Durrheim@hnehealth.nsw.gov.au

Dr J. Peter Figueroa (Linked by telephone) Professor, Public Health, Epidemiology & AIDS, Department of Community Health & Psychiatry Faculty of Medical Sciences University of the West Indies Mona Kingston 7 Jamaica

tel: +1 876-970-3252 fax: +1 876 967 1643 e-mail: peter.figueroa10@gmail.com

Dr Xiaofeng Liang

 

Director of National Immunization Programme China Center for Disease Control and Prevention - Ministry of Health China Center for Disease Control and Prevention

tel: +86 10 631 76 737 fax: + 86 10 631 71 724 e-mail: liangxf@hotmail.com

27

Nanwei Lu

Beijing 100050 People's Republic of China

Professor Elizabeth Miller (Unable to attend) Head Immunisation Department Health Protection Agency Centre for Infections

tel: 44 208 327 7430 (direct) fax: 44 208 327 7404 e-mail: Liz.Miller@hpa.org.uk

61

Colindale Avenue

London NW9 5EQ United Kingdom of Great Britain & Northern Ireland

Professor Helen Rees Professor Obstetrics & Gynaecology Reproductive Health and HIV Research Unit University of the Witwatersrand PO Box 18512 Hillbrow 2038 Johannesburg South Africa

tel: +27 11 358 5402 fax: +27 11 358 5301 e-mail: scornell@rhru.co.za; hrees@rhru.co.za;

Professor Arthur Lawrence Reingold Head, Division of Epidemiology School of Public Health University of California, Berkeley 140 Warren Hall Berkeley 94720-7360 CA United States of America

tel: +1 510 642 0327 fax: +1 510 643 5163 e-mail: Reingold@uclink4.berkeley.edu; reingold@berkeley.edu

Professor David Salisbury (Chair of SAGE and H1N1 Working Group) Director of Immunisation Department of Health Wellington House 510, Wellington House 133-155 Waterloo Road London SE1 8UG United Kingdom of Great Britain & Northern Ireland

tel: +44 207 972 4377 fax: +44 207 972 3989 e-mail: david.salisbury@dh.gsi.gov.uk

Dr Jane Soepardi Head of Sub-Directorate of Immunization Ministry of Health and Sanitation Jalan Percetakan Negara 20 P.O. Box 223 Jakarta 10560 Indonesia

tel: +62 21 754 4158 fax: +62 21 428 04 154 e-mail: janesoepardi@yahoo.com ;

Dr Oyewale Tomori Professor of Virology Redeemer's University Km 46 Lagos-Ibadan Express Road P.O. box 7914, IKEJA Lagos State Nigeria

tel: +234 1 793 1780 fax:

e-mail: oyewaletomori@yahoo.com; tomorio@run.edu.ng

H1N1 Working Group members

Dr Nancy J. Cox

 

Director, of Influenza Division, National Center for Immunization & Respiratory Diseases Centers for Disease Control and Prevention National Center for Infectious Diseases

tel: +1404 639 3591 fax: +1 404 639 2334 e-mail: njc1@cdc.gov

1600

Clifton Rd. NE

Atlanta, GA 30333 United States of America

Professor Neil Ferguson (Linked by telephone) Professor of Mathematical Biology MRC Centre for Outbreak Analysis and Modelling Imperial College St. Mary's Campus Norfolk PLace Paddington London W2 1PG United Kingdom of Great Britain & Northern Ireland

tel: +44 207 594 3296 fax: +44 207 262 3495 e-mail: neil.ferguson@imperial.ac.uk

Mrs Teeranart Jivapaisarnpong Director, Division of Biological Products Department of Medical Sciences Ministry of Public Health Nonthaburi 11000 Thailand

tel: +662 965 9723 fax: +662 5915448 e-mail: teena@health.moph.go.th; jnart@dmsc.moph.go.th

Professor Paul-Henri Lambert Center for Vaccinology Centre Médical Universitaire

tel: +41 22 379 5783 fax: +41 22 702 5801 e-mail: paul.lambert@unige.ch

1

rue Michel Servet

Genève 1211 Switzerland

4

 

Professor Joahnnes Lower President Paul-Ehrlich-Institut Paul Ehrlich Strasse 51-59 Postfach 1740 Langen 63225 Germany

tel: 496103771000 fax: 496103771240 e-mail: Loejo@pei.de

Dr Karen Midthun Deputy Director for Medicine

tel: +1 301 827 0372 fax: +1 301 827 0440 e-mail: karen.midthun@fda.hhs.gov

Center for Biologics Evaluation and Research

1401

Rockville Pike

200N (HFM-6) Rockville MD 20892 United States of America

 

Dr Philip Minor Head, Division of Virology (Chair ECBS) National Institute for Biological Standards and Control Blanche Lane, South Mimms Potters Bar Herts EN6 3QG United Kingdom of Great Britain & Northern Ireland

tel: +44 1707 641 312 fax: +44 1707 641 050 e-mail: Philip.Minor@nibsc.hpa.org.uk

Professor Albert Osterhaus Head of the Department of Virology Erasmus MC, Dr Molewaterplein 50 P.O. Box 2040 Rotterdam

tel: +31 10 704 4066 fax: 31 10 408 9485 e-mail: a.osterhaus@erasmusmc.nl

3000

CA

Netherlands

Dr Stefania Salmaso (Linked by telephone) Director Centro Nazionale di Epidemiologia CNESPS Istituto Superiore di Sanità Viale Regina Elena, 299

tel: +39 06 4990 4010 (4012-4013) fax: +39 06 49904111 e-mail: salmaso@iss.it

00161

Rome

Italy

Professor Peter Smith (Chair GACVS) Department of Epidemiology and Population Health London School of Hygiene and Tropical Medicine Keppel Street London WC1E 7HT United Kingdom of Great Britain & Northern Ireland

tel: +44 207 927 2246 fax: +44 207 927 2666 e-mail: Peter.Smith@lshtm.ac.uk

TCG/TAG Chairs

Dr Ciro de Quadros Executive Vice-President (AMRO TAG Chair) Sabin Vaccine Institute

tel: +1 202 265 6515 fax: +1 202 785 7689 e-mail: ciro.dequadros@sabin.org

2000

Pennsylvania Avenue NW

Suite 7100

 

Washington

20006

DC

United States of America

Dr Robert Hall Senior Research Fellow (WPRO TAG Chair) Monash University Department of Epidemiology and Preventive Medicine 85 Commercial Road Melbourne

tel: +61 3 9903 0555 fax:

e-mail:

robert.hall@med.monash.edu.au

3008

Victoria

Australia

Professor Lalitha Mendis President Sri Lanka Medical Council Emeritus Professor University of Colombo / Chairperson SEARO TAG on Immunisation University of Colombo 532/3G, Sirikotha Lane Colombo 3 Sri Lanka

tel: +94 11 2576907 fax: +94 11 269 8802 e-mail: sirikotha@yahoo.com

Dr Ali Jaffer Mohamed Advisor Health Affairs & Supervising DGHA (EMRO TAG Chair) Ministry of Health, Sultanate of Oman Ministry of Health P. O. Box 393 Muscat Oman

tel: +968 24 600808 fax: +968 24 691162 e-mail: dg-ha@moh.gov.om

Professor Peter Martins Ndumbe (Unable to attend) Dean, Faculty of Health Sciences, (AFRO TFI Chair (also Chair of IVAC) University of BUEA Molyko, PO Box 63 South West Province Buea Cameroon

tel: +237 3332 2134 / +237 3332 2813 fax: +237 3332 2813 e-mail: pndumbe@yahoo.com; pndumbe@gmail.com

Dr Pierre Van Damme (Unable to attend) Professor, Vaccine & Infectious Diseases Institute (EURO ETAGE Chair) WHO Collaborating Center for Control and Prevention of Viral Hepatitis University of Antwerp Centre for the Evaluation of Vaccination Universiteitsplein 1 Antwerp 2610 Belgium

tel: +32 3 820 25 38 fax: +32 3 820 26 40 e-mail: pierre.vandamme@ua.ac.be

Invited Experts

Dr Gary Grohmann FASM Director, Immunobiology & Manager of Prescription Medicines Office of Laboratories & Scientific Services Therapeutic Goods Administration P.O. Box 100 Woden ACT 2606 Australia

tel: 612 6 232 8490 fax: 612 6 232 8564 e-mail: gary@pathogens.com.au

Dr Frederick Hayden (Linked by telephone) Influenza Research Coordinator International activities-Science Funding The Wellcome Trust

tel: +44 20 7611 8256 fax: +44 207 611 7288 e-mail: f.hayden@wellcome.ac.uk

215

Euston Road

London NW1 2BE United Kingdom of Great Britain & Northern Ireland

Dr Arnold Monto Director, The University of Michigan Bioterrorism Preparedness Initiative The University of Michigan School of Public Health

tel: +1 734 764 5453 fax: +1 734 764 3192 e-mail: asmonto@umich.edu

109

Observatory St.

Ann Arbor 48109-2029 MI United States of America

 

Observers

Dr Marguerite Baxter VP Government Affairs Novartis Vaccines & Diagnostics

tel: +1 202 626-0100 fax:

701

Pennsylvania Ave NW, Suite 725

e-mail: marguerite.baxter@novartis.com

Washington, DC 20004 United States of America

Ms Janis Bernat Scientific Assistant International Federation of Pharmaceutical Manufacturers and Associations 15, chemin Louis-Dunant P.O. Box 195 1211 Geneva 20 Switzerland

tel: +41 22 338 3225 fax:

e-mail: j.bernat@ifpma.org

Mrs Francesca Boldrini Executive Director, Global Public Affairs EU and International Organizations Novartis Vaccines & Diagnostics WSJ 210.2.30

tel: +41 61 32 43 265 fax: +41 61 324 20 16 e-mail: francesca.boldrini@novartis.com

4002

Basel

Switzerland

 

Mr Olivier Brun Global Product Manager Crucell Berna Biotech Ltd. Rehhagstrasse 79 Bern

3018

tel: +41319806559 fax:

e-mail: olivier.brun@crucell.ch

Switzerland

 

Dr Sonia Villaseñor Bustamante Gerente de Exportaciones y Ventas Sector Privado International Business Manager Birmerx Amores 1240 Col del Valle del Benito Juarez

tel: (52-55) 5422-2873 fax: (52-55) 5422-2881 e-mail: svillasenorb@birmex.gob.mx

03100

 

Mexico

Dr Iza Ciglenecki Medical advisor - response to epidemics and epidemiological support Médecins Sans Frontières Switzerland 78, Rue de Lausanne CP 116

Tel. +41 22 849 8930 e-mail:

Iza.CIGLENECKI@geneva.msf.org

1211

Geneva

Switzerland

 

Mr Nathan Wilcox

telephone linked to listen

 

Oliver Wyman 10 South Wacker Drive, 13th Floor Chicago IL 60606 United States

tel: +1 312 902 7915 fax: +1 312 902 7989

e-mail: Nathan.Wilcox@oliverwyman.com

Dr Alfred Da Silva Executive Director Agence de Médecine préventive s/c Institut Pasteur 25-28 rue du Dr Roux 75724 Paris Cedex 15 France

tel: 33 1 53 86 89 20 fax: 33 1 53 86 89 39 e-mail: ads@aamp.org

Dr Stephen Gardner Director Market Access Influenza GlaxoSmithKline Parc de la Noire Epine Avenue Fleming 20 Wavre 1300 Belgium

tel: +32 2 656 92 67 fax: +32 2 656 81 27 e-mail: stephen.x.gardner@gskbio.com

Dr Bruce Gellin Director Departement of health and Human Services 200 Independence Avenue SW Washington, DR 20201 United States

tel: 202- 690 55 66 fax: 202-690 46 31 e-mail:bruce-gellin@hhs-gov

Dr Jesse L. Goodman Director

tel: + 1 301 827 0372 fax: + 1 301 827 0440 e-mail: jgoodman@cber.fda.gov; jesse.goodman@fda.hhs.gov

Center for Biologics Evaluation and Research

US

Food and Drug Administration (FDA)

1401 Rockville Pike, Suite 200N

 

Rockville

 

MD

20852-1448

United States of America

Mr Toru Gotanda Deputy President Kitasato Institute Biological Research Center 6-111 Arai Kitamotoshi Saitamaken 364-0026 Japan

tel: +81-48 593 3957 fax: +81 48 593 3851 e-mail: tgotanda@insti.kitasato-u.ac.jp

Ms Stephanie Hardy Senior Policy Advisor - Vaccines Biologics and Genetic Therapies Directorate Health Canada Tunney's Pasture Ottawa K1A 0L2 Ontario Canada

tel: 1.613.957.8228 fax:

e-mail: stephanie_hardy@hc-sc.gc.ca

Dr Norbert Hehme Chairman, IVS International Task Force, Vice President Flu Manufacturing Strategy GSK Biologicals Zirkusstrasse 40, Dresden 01069 Germany

tel: +49 351 546 15104 fax: +49 351 456 15321 e-mail: norbert.w.hehme@gskbio.com

Dr Jennifer Herz Medimmune 7 rue Sully Lyon 69006 France

tel: +33 6 16 80 47 26 fax:

e-mail: herzj@medimmune.com

Ms Sissel Hodne Steen Minister Counsellor Permanent Mission of Norway to the United Nations Office & other International Organizations at Geneva 31-35 Avenue de Budé Geneva 1202 Switzerland

tel: +41229180423 fax: +41229180410 e-mail: shst@mfa.no

Dr Suresh S. Jadhav Executive Director Quality Assurance & Regulatory Affairs Serum Institute of India Limited 212/2 Hadapsar Pune 411 028 India

tel: +91 202 699 3900/26602379 fax: +91 202 699 3945/3921 e-mail: ssj@seruminstitute.com

Dr Ryoko Krause Director Biologicals and Vaccines International Federation of Pharmaceutical Manufacturers and Associations 15, chemin Louis-Dunant P.O. Box 195

tel: +41 22 338 3212 fax: +41 22 338 3299 e-mail: r.krause@ifpma.org

1211

Geneva 20

Switzerland

Dr Cornelia Kutzer Senior Marketing Manager Global BioSecurity Baxter BioScience Baxter Hyland Immuno, Ufer Str. 15 Orth/Donau 2304 Austria

tel: +43 1 20100 1349 fax: +43 1 20100 5073 e-mail: cornelia_kutzer@baxter.com

Consellor Thor Erik Lindgren Permanent Mission of Norway to the United Nations Office & other International Organizations at Geneva 31-35 Avenue de Budé Geneva 1202 Switzerland

tel: +41229180423

fax: +41229180410

e-mail: tel@mfa.no

Professor Pierluigi Lopalco European Centre for Disease Prevention and Control Stockholm 171 83 Sweden

tel: +46 8 586 01 212 fax: +46 8 5860 1001 e-mail: pierluigi.lopalco@ecdc.europa.eu

Dr Dorothea Matysiak-Klose Robert Koch Institut DGZ - Ring 1 13068 Berlin Germany

tel: +49 30 4547 3414 fax: +49 30 4547 3533 e-mail: matysiak-klose@rki.de

Dr Nobuhiko Okabe Director Division of Surveillance and Information National Institute of Infectious Diseases Infectious Disease Surveillance Centre 1-23-1 Toyama Shinjuku Tokyo 162 8640 Japan

tel: +81 3 5285 1111 fax: +81 3 5285 1129 e-mail: okabenob@nih.go.jp

Dr Bram Palache

 

Global Scientific and Public Affairs Director Influenza Vaccines Solvay Biologicals PO Box 900

tel: +31 294 477542 fax: +31 294 417772 e-mail: bram.palache@solvay.com

1380

DA Weesp

Netherlands

Professor Christian Perronne Infectious Diseases Unit Hôpital Universitaire Raymond Poincaré Garches 92380 France

tel: +33 1 47 10 77 58 fax: +33 1 47 10 77 67 e-mail: c.perronne@rpc.aphp.fr

Mr Jon Pearman GAVI Manager Accelerated Vaccine Introduction (AVI) GAVI Alliance Secretariat Geneva 10 Switzerland

tel: +41 22 909 65 30 fax: +41 22 909 65 50 mobile: +41 79 240 48 63 e-mail:jpearman@gavialliance.org

Dr Samuel Ponce de León General Director Laboratorios de Biologicos y Reactivos de Mexico, S.A. de C.V Amores 1240 Colonia del Valle 06000 Mexico DF Mexico

tel: (52) 54-22-28-40 y (52) 54-22- fax: (52) 54-22-28-80 y (52) 54-22- e-mail: sponcedeleonr@birmex.gob.mx

Dr Sai D.Prasad Project Manager – Rotavirus Vaccine Project Vice President Genome Valley Shameerpet, Hyderabad 500 078. A.P. India

tel: +91 40 2348 0567 fax: +91 40 2348 0560 e-mail: prasadsd@bharatbiotech.com

Dr Manjari Quintanar Subdirector of the Coordination of the National Immunization Council Centro Nacional para la Salud de la Infancia y la Adolescencia Francisco de P. Miranda No. 177 1er. piso Col. Merced Gómez Deleg. Álvaro Obregón Mexico D.F. Mexico

tel:

fax:

e-mail: mwonji@yahoo.com.mx

Dr David Ryan

   

Technical Director Vaccines, CSL Pharmaceuticals Product Development

tel: +61 3 9389 1911 fax: + 61 3 9389 1434 e-mail: David.Ryan@cs1.com.au

45

Poplar Road

Parkville

 

Victoria 3052

Australia

Mr Adam Sabow, Partner Oliver Wyman

telephone linked to listen

tel: +1 312 902 7915 fax: +1 312 902 7989

10

South Wacker Drive, 13th Floor

Chicago

 

e-mail: adam.sabow@oliverwyman.com

IL 60606

United States

Professor Claire-Anne Siegrist Director of Pediatric Department Center for Vaccinology and Neonatal Immunology CMU 1 rue Michel-Servet, 1211 Geneva 4 Switzerland

tel: +22 379 57 78 fax: +22 379 58 01

e-mail: Claire-Anne.Siegrist@unige.ch

Dr Susan Tamblyn Public Health Consultant Public Health Agency in Canada Public Health Agency of Canada Tunney's Pasture PL 0602D Ottawa, Ontario K1A OK9 Canada

tel: 6138526036 fax:

e-mail: susan_tamblyn@phac- aspc.gc.ca

Dr Russell Thirsk

 

Novartis Vaccines and Diagnostics Inc.

tel: +1 617 871 7998 fax:

350

Massachusetts Avenue

MA 02139 Cambridge United Kingdom of Great Britain & Northern Ireland

e-mail: Russell.Thirsk@novartis.com

Mr Mayuko Toyota First Secretary

tel: +41-22-717-3107 fax: +41-22-717-3774 e-mail: mayuko.toyota@ge-japan.ch

Permanent Mission of Japan in Geneva 3,chemin des Fins

1218

Grand-Saconnex

 

Genève

Suisse

Dr Ronald Waldman

 

U.S. Agency for International Development (USAID) Ronald Reagan Building

tel:

fax:

1300

Pennsylvania Avenue N.W.

e-mail: rwaldman@usaid.gov

Washington, D.C.

 

20523-3700

United States of America

Professor Albrecht Werner European Commission SANCO C Health Threats Unit HTC 02/264 11, Rue E. Ruppert

tel: 00352 4301 35290 fax:

e-mail:Albrecht.WERNER@ec.europa.eu

2920

Luxembourg

Ms Kine Willbergh Senior Adviser Norwegian Institute of Public Health PO Box 4404, Nydalen Oslo 0403 Norway

tel: +4721076494 fax: +4721076301 e-mail: kine.willbergh@fhi.no

Observers by telephone link

Dr Atika Abelin Director, Public Affairs Director, Public Affairs (IFPMA IVS Policy member) Sanofi Pasteur 2, avenue Pont Pasteur 69367 Lyon France

tel: +33 4 37377952 fax: +33 437377202 e-mail:

Dr Marguerite Baxter VP Government Affairs

tel: +1 202 626-0100 fax:

Novartis Vaccines & Diagnostics

701

Pennsylvania Ave NW, Suite 725

e-mail: marguerite.baxter@novartis.com

Washington, DC 20004 United States of America

Mrs Francesca Boldrini Executive Director, Global Public Affairs EU and International Organizations Novartis Vaccines & Diagnostics WSJ 210.2.30

tel: +41 61 32 43 265 fax: +41 61 324 20 16 e-mail: francesca.boldrini@novartis.com

4002

Basel

Switzerland

Mr John Budd Chief of Communication CEE CIS Region UNICEF (Geneva) 57 avenue de la Paix (Palais des Nations)

tel: +41229095429 fax:

e-mail: jbudd@unicef.org

1211

Genève 10

Switzerland

Dr Kathleen L. Coelingh Senior Director Medical & Scientific Affairs MedImmune Inc. 801 Pine Street, Apartment 25A, Seattle, 98101 WA United States of America

tel: +1 206 695 2823 fax: +1 650 603 3396 e-mail: coelinghk@medimmune.com

Dr Toon Digneffe Director Governmental Affairs Baxter World Trade sa Bd de la Plaine Brussels 1050 Belgium

tel: +32 2 650 1672 fax:

e-mail: toon_digneffe@baxter.com

Dr Anne Golaz Senior Health Advisor - Emergencies UNICEF 5-7 Avenue de la Paix

tel: +977 1 4419 471 fax: +977 1 4419 471 e-mail: agolaz@unicef.org

1211

Genève 10

Switzerland

Dr Emmanuel Hanon Vice-President, Head of Influenza Vaccine Franchise GlaxoSmithKline Biologicals rue de l'institut 89 Rixensart Belgium

tel: +32 10 85 3319 fax:

e-mail: emmanuel.hanon@gskbio.com

Dr Luc Hessel Executive Director Sanofi Pasteur MSD 8 Rue Jonas Salk 69367 Lyon Cedex 07 France

tel: +33 437 28 40 70 fax: +33 437 28 44 11 e-mail: lhessel@spmsd.com

Dr Douglas Holtzman Senior Program Officer, Infectuous Diseases Global Health Program The Bill and Melinda Gates Foundation P.O. Box 23350 Seattle 98102 WA United States of America

tel: (206)709-3601 fax: (206)709-3170 e-mail:

Douglas.Holtzman@gatesfoundation.org

Dr Tomia Ikeda Deputy General Manager Vaccine R&D Department Denka Seiken Co. Ltd. 1-2-2 Minami-Honcho Gosen -shi, Niigata 959-1695 Japan

tel: +81 250 43 4111 fax: +81 250 43 4252 e-mail: tom-ikeda@denka-seiken.co.jp

Dr Yoichiro Kino General Manager Second Research Department The Chemo-Sero-Therapeutic Research Institute (KAKETSUKEN) 1-6-1 Okubo Kumamoto, 860-8588 Japan

tel: 81 968 37 4090 fax: +81 968 37 4350 e-mail: kino-yo@kaketsuken.or.jp

Dr Igor Krasilnikov Chief, Department of Research Microgen State Company Kozhevnichesky proesd, 4/3 115114 Moscow Russian Federation

tel: +007 495-790-77-73 fax: +007 495- 790-77-73 e-mail: krasilnikov@bio.ru or lobastova@bio.ru

Ms Christine Ding-Ping Liu Director Division of Acute Infectious Diseases & Immunization Centers for Disease Control Department of Health No. 6, Linshen South Road, 100 Taiwan (Chinese Taipei)

tel: +886-2-23959836 fax: +886-2-23945308 e-mail: dpliu@cdc.gov.tw

Dr Osman Mansoor Public Health Physician Senior Adviser EPI (New Vaccines) UNICEF 3 United Nations Plaza New York 10017 NY United States of America

tel: 1 212 326 74 10 fax: 1 212 824 64 60 e-mail: omansoor@unicef.org

Dr Kathy Neuzil

 

Senior Clinical Adviser Program for Appropriate Technology in Health

tel: +1 206 285 3500 fax: 1 206 285 6619 e-mail: kneuzil@path.org

 

1455

NW Leary Way

Seattle 98107 5136 WA United States of America

 

Mrs Beatrice Progida Emergency preparedness specialist Pandemic focal point UNICEF

tel: +41229095641 fax:

e-mail: bprogida@unicef.org

57

avenue de la Paix (Palais des Nations)

1211

Genève 10

Switzerland

Dr Regina Rabinovich Director Infectious Diseases, Global Health Program The Bill and Melinda Gates Foundation P.O. Box 23350 Seattle, WA 98107-5136 United States of America

tel: +1 206 709 3490/3579 fax: +1 206 709 3170 e-mail:

regina.rabinovich@gatesfoundation.org

Dr David Ryan Technical Director Vaccines, CSL Pharmaceuticals Product Development

tel: +61 3 9389 1911 fax: + 61 3 9389 1434 e-mail: David.Ryan@cs1.com.au

45

Poplar Road

Parkville

Victoria 3052

Australia

Professor Barry D. Schoub Executive Director National Institute for Communicable Diseases Private Bag X4 Sandringham 2131 South Africa

tel: +27 11 38 66 390 fax: +27 11 38 66 455 e-mail: barrys@nicd.ac.za

Dr R.K. Suri Senior Vice President New Initiative Panacea Biotech Ltd. B-1 Extension A-27 Mohan Co-op. Indl. Estate, Mathura Rd New Delhi India

tel: +91 11 41 67 90000 Extn. 2064 fax: +91 11 4167 9027 e-mail: rksuri@panaceabiotec.com

Dr Masato Tashiro Director Department of Virology III (Viral Diseases & Vaccine Control) National Institute of Infectious Diseases WHO Collaborating Centre for Reference & Research of Influenza Gakuen 4-7-1 Musashi-Murayama Tokyo 208-0011 Japan

tel: 81 42 565 2498 fax: 81 42 565 2498 e-mail: mtashiro@nih.go.jp

Mr Jaap Venema Global Project Director Pandemic Solvay Biologicals PO Box 900 1380 DA Weesp Netherlands

tel: +31 294 479537 fax: +31 294 417772 e-mail: Jaap.Venema@solvay.com

Dr Richard Webby Department of Infectious Diseases 262 Danny Thomas Place Memphis TN 38105 United States of America

tel: +1 901 595 3014 fax: +1 901 523 2622 e-mail: Richard.Webby@stjude.org

Dr Ferenc Zimonyi Chief Executive Officer Ömninvest Vaccines Omnivest Vaccines Fö utca 7 Pilisborosjenö 2097 Hungary

tel:

fax: +36 26 536 051 e-mail: f.zimonyi@omninvest.hu

Dr Yong Zou Medicine Manager Sinovac Biotech Ltd No 39 Shangdi Xi Road Haidian District Beijing 100085 People's Republic of China

tel: +86 10 82799340 fax:

e-mail: zouyong99@126.com

Regional Offices

Dr Déo Nshimirimana Regional Adviser for VPD Regional Office for Africa (AFRO) Vaccine Preventable Diseases Division of Prevention and Control of Communicable Diseases Boîte Postale 6 Brazzaville Congo

tel: Ext.39203 fax: +47 241 39 501/3 e-mail: nshimirimanad@afro.who.int

Dr Cuauhtémoc Ruiz Matus Regional Adviser/Unit Chief of Immunization Regional Office for the Americas (AMRO/PAHO) Immunization Unit, Room 511 252, 23rd Street Washington D.C. 20037 2895 United States of America

tel: 5200 3945 fax:

e-mail: ruizcuau@paho.org

Dr Jaouad Mahjour (Unable to attend) Director, Communicable Diseases Control Regional Office for Eastern Mediterranean (EMRO) Abdul Razzak Al-Sanhouri Street P.O. Box 760 8, Nasr City Cairo 11371 Egypt

tel: +20 222 765 250 fax: +20 222 765 414 e-mail: mahjourj@emro.who.int

Dr Rebecca Martin Targeted Diseases and Immunization Team Leader Communicable Diseases Unit (CDS) Regional Office for Europe (EURO) 8, Scherfigsvej Copenhagen 2100 Denmark

tel: +45 3917 1216 fax: +45 3917 1863 e-mail: rma@euro.who.int

Headquarters Secretariat

Dr.Asamoa-Baah Deputy Director-General DGD/DGO/ODG

tel: +

41 22 791 44 19

e-mail: aylwardb@who.int

Dr. Bruce Aylward Director Polio Eradication Initiative (POL)

tel: +

41 22 791 44 19

e-mail: aylwardb@who.int

Dr Sylvie Briand Global Influenza Programme (GIP) Epidemic and Pandemic Alert and Response (EPR) Communicable Diseases (CDS)

tel: +

41 22 791 2372

e-mail: briands@who.int

Mr Peter Carrasco Expanded Programme on Immunization (EPI) Immunization, Vaccines and Biologicals (IVB)

tel: +

41 22 791 1512

e-mail: carrascop@who.int

Dr Sudeep Chand Public Health Advisor (IVB)

tel: +44 75000 87002 e-mail: Sudeep.Chand@dh.gsi.gov.uk

Dr Thomas Cherian Coordinator Expanded Programme on Immunization (EPI) Immunization, Vaccines and Biologicals (IVB)

tel: +

41 22 791 4460

e-mail: cheriant@who.int

Mr Alejandro Costa Epidemic Readiness and Interventions (ERI) Epidemic and Pandemic Alert and Response (EPR)

tel: +

41 22 791 4965

e-mail: costaa@who.int

Dr Philippe Duclos Senior Health Adviser/SAGE Executive Secretary Immunization Policy (ICP) Immunization, Vaccines and Biologicals (IVB)

tel: +

41 22 791 4527

e-mail: duclosp@who.int

Dr Martin Friede Product Research and Development (RPD) Initiative for Vaccine Research (IVR) Immunization, Vaccines and Biologicals (IVB)

tel:

41 22 791 4398

e-mail: friedem@who.int

Dr Florence Fuchs Laboratory Quality Systems Lyon

tel:

e-mail: fuchsf@who.int

Dr Keiji Fukuda Global Influenza Programme (GIP) Epidemic and Pandemic Alert and Response (EPR) Communicable Diseases (CDS)

tel: +

41 22 791 3871

e-mail: fukudak@who.int

Dr Prakash Ghimire Epidemic and Pandemic Alert and Response (EPR) Global Influenza Programme (GIP)

tel. +41 22 791 2463 e-mail: ghimirep@who.int

Dr Marie-Paule Kieny Director Initiative for Vaccine Research (IVR) Immunization, Vaccines and Biologicals (IVB)

tel: +

41 22 791 3591

e-mail: kienym@who.int

Dr Jean-Marie Okwo-Bele Director Immunization, Vaccines and Biologicals (IVB)

tel: +

41 22 791 2779

e-mail: okwobelej@who.int

Dr Laszlo Palkonyay Product Research and Development (RPD) Initiative for Vaccine Research (IVR) Immunization, Vaccines and Biologicals (IVB)

tel: +

41 22 791 3488

e-mail: palkonyayl@who.int

Dr Dina Pfeifer Quality, Safety and Standards (QSS) Immunization, Vaccines and Biologicals (IVB)

tel: +

41 22 791 2978

e-mail: pfeiferd@who.int

Dr Cathy Roth Epidemic and Pandemic Alert and Response (EPR) Biorisk Reduction for Dangerous Pathogens (BDP)

tel: +

41 22 791 3896

e-mail: rothc@who.int

Dr Niteeen Wairagkar Epidemic and Pandemic Alert and Response (EPR) Global Influenza Programme (GIP)

tel: +

41 22 791 3786

e-mail: wairagkarn@who.int

Dr David Wood Coordinator Quality, Safety and Standards (QSS) Immunization, Vaccines and Biologicals (IVB)

tel: +

41 22 791 4050

e-mail: woodd@who.int

Dr Wenqing Zhang Epidemic and Pandemic Alert and Response (EPR) Global Influenza Programme (GIP)

tel: +

41 22 791 4282

e-mail: zhangw@who.int

Dr Patrick Zuber Expanded Programme on Immunization (EPI) Immunization, Vaccines and Biologicals (IVB)

tel: +

41 22 791 1521

e-mail: zuberp@who.int